CARCINOSARCOMA
Clinical trials for CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
New hope for aggressive uterine cancer: drug combo targets Obesity-Linked tumors
Disease control Recruiting nowThis early-stage study tests the safety of combining two drugs, atezolizumab and ONC201, for women with advanced or recurrent endometrial cancer. The trial includes both obese and non-obese participants to see how body weight affects treatment. Researchers aim to find the best do…
Matched conditions: CARCINOSARCOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Massive german sarcoma registry aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study is a large registry that will collect information from up to 9,000 people in Germany who have been diagnosed with sarcoma or carcinosarcoma. The goal is to gather data on how often different types of sarcoma occur, their outcomes, and how they are treated. No new treat…
Matched conditions: CARCINOSARCOMA
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC